Pancreatic Adenocarcinoma Non-resectable Clinical Trials in Ann Arbor, Michigan

A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer